Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Anika Therapeutics Inc before investing.

In this article, we go over a few key elements for understanding Anika Therapeutics Inc’s stock price such as:

• Anika Therapeutics Inc’s current stock price and volume
• Why Anika Therapeutics Inc’s stock price changed recently
• Upgrades and downgrades for ANIK from analysts
• ANIK’s stock price momentum as measured by its relative strength

About Anika Therapeutics Inc (ANIK)

Before we jump into Anika Therapeutics Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Anika Therapeutics, Inc. is a joint preservation company. The Company is engaged in creating and delivering advancements in early intervention orthopedic care, including osteoarthritis (OA) pain management, regenerative solutions, sports medicine and Arthrosurface joint solutions. The Company is focused on developing, manufacturing, and commercializing products based on its hyaluronic acid (HA) technology platform. The Company?s product line includes OA Pain Management, Joint Preservation and Restoration, and Non-Orthopedic. Its OA Pain Management product consists of Monovisc and Orthovisc, Cingal, and Hyvisc. Its Joint Preservation and Restoration consist of regenerative solutions, sports medicine, and Arthrosurface joint solutions. Monovisc and Orthovisc are single and multi-injection, HA-based Visco supplement products, Cingal, and Hyvis. Its Non-Orthopedic products consists of HA-based products that are marketed principally for non-orthopedic applications.

Want to learn more about Anika Therapeutics Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Anika Therapeutics Inc.

Anika Therapeutics Inc’s Stock Price as of Market Close

As of February 23, 2024, 4:00 PM, CST, Anika Therapeutics Inc’s stock price was $25.89.

Anika Therapeutics Inc is up 4.27% from its previous closing price of $24.83.

During the last market session, Anika Therapeutics Inc’s stock traded between $24.19 and $25.26. Currently, there are 14.64 million shares of Anika Therapeutics Inc stock available for purchase.

Unfortunately, Anika Therapeutics Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Anika Therapeutics Inc Stock Price History

Anika Therapeutics Inc’s (ANIK) price is currently up 10.08% so far this month.

During the month of February, Anika Therapeutics Inc’s stock price has reached a high of $26.33 and a low of $22.82.

Over the last year, Anika Therapeutics Inc has hit prices as high as $32.17 and as low as $16.54. Year to date, Anika Therapeutics Inc’s stock is down 12.53%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Anika Therapeutics Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of February 22, 2024, there were 0 analysts who downgraded Anika Therapeutics Inc’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Anika Therapeutics Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Anika Therapeutics Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Anika Therapeutics Inc’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Anika Therapeutics Inc (ANIK) by visiting AAII Stock Evaluator.

Relative Price Strength of Anika Therapeutics Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of February 22, 2024, Anika Therapeutics Inc has a weighted four-quarter relative price strength of -6.28%, which translates to a Momentum Score of 50 and is considered to be Average.

Want to learn more about how Anika Therapeutics Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Anika Therapeutics Inc Stock Price: Bottom Line

As of February 23, 2024, Anika Therapeutics Inc’s stock price is $25.89, which is up 4.27% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Anika Therapeutics Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.